Life sciences

  • MedTech companies Paxman and Dignitana announce merger

    Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new chapter of working together to advance side effect management for cancer patients around the world. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB [...]

  • From crisis to resilience: how clinical trials can absorb future trade shocks through AI and blockchain

    By Martin Sandhu, healthtech founder & technology consultant The last global crisis changed clinical trials forever. When COVID-19 closed physical sites and restricted movement, the industry had no choice but to evolve. Decentralised clinical trials (DCTs)—once an emerging trend—became a necessity. The shift wasn’t seamless or universal. Smaller firms struggled with infrastructure, and many trials [...]

  • Gifthealth appoints Chip Parkinson as CEO

    Gifthealth, a technology-driven pharmacy care company dedicated to making prescription access easier and more affordable, has announced the appointment of Chip Parkinson as its new Chief Executive Officer. A veteran healthcare executive with three decades of experience, Parkinson brings deep leadership expertise across biotechnology, pharmacy benefit management, diagnostics, and pharmaceutical industries. His extensive background includes [...]

  • Exoskeleton technology used in double lung transplant in world first trial

    The world’s first double lung transplant using AI enabled exoskeleton technology has taken place at a British hospital. The technology, which was supplied by wearable tech and safety company, Stanley, was trialled as part of a seven hour overnight operation on a 62 year old female with end stage lung disease. Using the technology in this [...]

  • Twelve arrested in MHRA’s biggest ever crackdown on organised medicines trafficking

    Twelve suspects have been arrested in dawn raids in four counties across the West Midlands and the Northwest of England this morning (29 April) in the largest criminal investigation into organised medicines trafficking in the history of the Medicines and Healthcare products Regulatory Agency (MHRA). The individuals have been arrested on suspicion of participating in [...]

  • Two ‘world first’ AML trials horizon on World AML Awareness Day

    Charity Cure Leukaemia has announced two world-first Acute Myeloid Leukaemia (AML) clinical trials that will target patients who can’t undergo chemotherapy. Acute myeloid leukaemia (AML) is a type of blood cancer and can affect children of any age. The EVOLVER trials are announced on World AML Awareness Day and come following ongoing investment in the [...]

  • LISTEN: Jimmy Carter: An immunotherapy legacy

    Late US President Jimmy Carter became a vocal advocate for immunotherapy after his melanoma was successfully treated with the drug pembrolizumab (Keytruda) in 2015. In the new episode of the Health Tech World Podcast, Cancer Research Institute CEO Dr Alicia Zhou discusses the President's role in accelerating awareness of immunotherapy, as well as the most [...]

  • Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

    Clinical and genomic data company Nashville Biosciences LLC (NashBio) and global DNA sequencing company Illumina Inc. today announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative. Insights from the AGD database are being leveraged to accelerate drug target discovery, therapeutic research and clinical development. Todd Christian is Senior [...]

  • NHS patients to get ‘take at home’ multiple sclerosis tablet in Europe first

    Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out widely to patients with active disease. The tablet, cladribine, requires just 20 days of treatment spread over four years, providing [...]

  • Groundbreaking UK precision medicine project advanced targeted childhood cancer treatments

    As part of a new programme to advance precision medicine in the UK, new genetic testing has enabled childhood cancer patients to receive targeted and less toxic treatments. The first phase of the Stratified Medicine Paediatrics (SMPaeds1) programme aims to advance precision medicine for children and young people whose cancer has returned. The project focused [...]